Evidence map›Paper›PMID 41623298›Full record

ArticleKidney medicine2026

Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine Project.

Christine P Limonte, Stephanie Aw, Charles E Alpers, Laura Barisoni, Brooke Berry, Frank C Brosius, Kirk N Campbell, Leal C Herlitz, Zoltan Laszik, Gearoid McMahon and 14 more

Abstract read
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Christine P LimonteDivision of Nephrology, University of Washington, Seattle, WA; Kidney Research Institute, University of Washington, Seattle, WA.
Stephanie AwDepartment of Pathology, Boston Medical Center and Boston University, Boston, MA.
Charles E AlpersDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Laura BarisoniDepartment of Pathology, Duke University School of Medicine, Durham, NC.
Brooke BerryCollaborative Health Studies Coordinating Center, University of Washington, Seattle, WA.
Frank C BrosiusDivision of Nephrology, The University of Arizona College of Medicine Tucson, Tucson, AZ.
Kirk N CampbellDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Leal C HerlitzDepartment of Anatomic Pathology, Cleveland Clinic, Cleveland, OH.
Zoltan LaszikDivision of Surgical Pathology, University of California San Francisco School of Medicine, San Francisco, CA.
Gearoid McMahonRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Amy MottlDivision of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC.
Patrick NachmanDivision of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN.
Yunbi NamDivision of Nephrology, University of Washington, Seattle, WA.
Emilio E PoggioDepartment of Kidney Medicine, Medical Subspecialties Institute, Cleveland Clinic, Cleveland, OH.
Parmjeet S RandhawaDepartment of Pathology, Thomas E. Starzl Transplant Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Sylvia E RosasKidney and Hypertension Unit, Joslin Diabetes Center, Boston, MA; Harvard Medical School, Boston, MA.
Isaac E StillmanDivision of Anatomic Pathology, Beth Israel Deaconess Medical Center, Boston, MA.
Jonathan J TaliercioDepartment of Kidney Medicine, Medical Subspecialties Institute, Cleveland Clinic, Cleveland, OH.
Jose TorrealbaDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX.
Katherine TuttleDivision of Nephrology, University of Washington, Seattle, WA; Kidney Research Institute, University of Washington, Seattle, WA.
Miguel VazquezDivision of Nephrology, UT Southwestern Medical Center, Dallas, TX.
Ian H de BoerDivision of Nephrology, University of Washington, Seattle, WA; Kidney Research Institute, University of Washington, Seattle, WA.
Joel HendersonDepartment of Pathology, Boston Medical Center and Boston University, Boston, MA.
Kidney Precision Medicine Project

Funding

Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
KPMP Kidney Mapping and Atlas Project (KMAP)U01DK133090 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$10.4M
Single cell multiomic and spatial atlas of acute and chronic kidney injuryU01DK114933 · NIDDK · WASHINGTON UNIVERSITY · PI Sanjay Jain · 2022 to 2026
$5.0M
Boston Chronic Kidney Disease Research Biopsy CenterU01DK133092 · NIDDK · BOSTON MEDICAL CENTER · PI Sylvia E Rosas, Sushrut S. Waikar · 2022 to 2026
$3.5M
University of Illinois at Chicago KPMP CKD Recruitment SiteU01DK133081 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAMES P. LASH, Ana Catherine Ricardo · 2022 to 2026
$2.7M
Cleveland Precision Medicine Chronic Kidney Disease CohortU01DK114908 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI JOHN F. O'TOOLE, EMILIO DANIEL POGGIO · 2022 to 2026
$2.2M
Geographic and Environmental Representation in Kidney Precision MedicineU01DK133095 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Frank C Brosius, Amy Mottl · 2022 to 2026
$2.1M
NIDDK NIH HHS U01 DK114908NIDDK NIH HHS U01 DK114933NIDDK NIH HHS U01 DK133081NIDDK NIH HHS U01 DK133090NIDDK NIH HHS U01 DK133092NIDDK NIH HHS U01 DK133095NIDDK NIH HHS U24 DK114886
6 · The paper itself

Abstract

Rationale & Objective: The Kidney Precision Medicine Project is obtaining kidney biopsies from people with chronic kidney disease (CKD) and acute kidney injury for comprehensive clinical, histopathological, and molecular characterization. Here, we describe histopathological findings from a subset of kidney biopsies from adults with CKD. Study Design: Descriptive case series of histopathology findings from adjudicated CKD biopsies. Setting & Participants: Kidney Precision Medicine Project enrolled adults with CKD and diabetes (DKD) and/or hypertension (HCKD) with persistent eGFR 30-59 mL/min/1.73 m Exposures: This is a descriptive study without defined exposures. Outcomes: Characterization of glomerular, tubulointerstitial, and vascular histopathological features across CKD biopsies. Analytical Approach: Continuous variables were summarized as mean (standard deviation) or median (interquartile range); categorial variables were summarized as count (percentage). Results: Participants' mean age was 59 years, 59% were female. Mean eGFR was 55 mL/min/1.73 m Limitations: Small sample size and lack of longitudinal data limit generalizability. Conclusions: Kidney biopsies in people with common causes of CKD demonstrate a broad range of histopathology and may have clinical utility. Unsuspected disease processes and unexpected and nonspecific findings precluding a definitive diagnosis are often present.

Indexed as

Chronic kidney diseasediabeteshistopathologyhypertensionkidney biopsy

Identifiers

PMID41623298
PMCPMC12859248

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.